0001062993-19-002771.txt : 20190702 0001062993-19-002771.hdr.sgml : 20190702 20190702123153 ACCESSION NUMBER: 0001062993-19-002771 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190702 DATE AS OF CHANGE: 20190702 EFFECTIVENESS DATE: 20190702 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aleafia Health Inc. CENTRAL INDEX KEY: 0001754664 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-343327 FILM NUMBER: 19936031 BUSINESS ADDRESS: STREET 1: 8810 JANE STREET, 2ND FLOOR CITY: CONCORD STATE: A6 ZIP: L4K2M9 BUSINESS PHONE: 902-405-4600 MAIL ADDRESS: STREET 1: 8810 JANE STREET, 2ND FLOOR CITY: CONCORD STATE: A6 ZIP: L4K2M9 D 1 primary_doc.xml X0708 D LIVE 0001754664 Aleafia Health Inc. 8810 JANE STREET, 2ND FLOOR CONCORD A6 ONTARIO, CANADA L4K2M9 416 860-5665 ONTARIO, CANADA Canabo Medical Inc. None Corporation true Geoffrey Benic 8810 Jane Street, 2nd Floor Concord A6 ONTARIO, CANADA L4K 2M9 Executive Officer Benjamin Ferdinand 8810 Jane Street, 2nd Floor Concord A6 ONTARIO, CANADA L4K 2M9 Executive Officer Julian Fantino 8810 Jane Street, 2nd Floor Concord A6 ONTARIO, CANADA L4K 2M9 Director Raf Souccar 8810 Jane Street, 2nd Floor Concord A6 ONTARIO, CANADA L4K 2M9 Director Daniel Milliard 8810 Jane Street, 2nd Floor Concord A6 ONTARIO, CANADA L4K 2M9 Director Mark Sandler 8810 Jane Street, 2nd Floor Concord A6 ONTARIO, CANADA L4K 2M9 Director William Stewart 8810 Jane Street, 2nd Floor Concord A6 ONTARIO, CANADA L4K 2M9 Director Loreto Grimaldi 8810 Jane Street, 2nd Floor Concord A6 ONTARIO, CANADA L4K 2M9 Director Lea Ray 8810 Jane Street, 2nd Floor Concord A6 ONTARIO, CANADA L4K 2M9 Director Other Decline to Disclose 06b false 2019-06-27 false true true true true Each Unit consist of 1 CAD$1000 unsecured convertible debenture with interest at 8.5% per annum & 680 common share purchase warrants exercisable for CAD$1.55 per share for 3 years from the closing date. false 0 Mackie Research USA Inc 39670 None None 199 Bay Street, Suite 4500 Toronto A6 ONTARIO, CANADA M5L 1G2 NY NEW YORK false 70496 34321 36175 Each Unit consist of 1 CAD$1000 unsecured convertible debenture with interest at 8.5% per annum & 680 common share purchase warrants exercisable for CAD$1.55 per share for 3 years from the closing date. false 1 2059 0 6% of gross proceeds 0 false Aleafia Health Inc. /s/ Benjamin Ferdinand Benjamin Ferdinand Chief Financial Officer 2019-07-02